Abstract
This study aims to explore how couples’ understanding of the nature and consequences of positive prenatal chromosomal microarray analysis (CMA) results impacts decision-making and concern about pregnancy. We interviewed 28 women and 12 male partners after receiving positive results and analyzed the transcripts to assess their understanding and level of concern about the expected clinical implications of results. Participant descriptions were compared to the original laboratory interpretation. When diagnosed prenatally, couples’ understanding of the nature and consequences of copy number variants (CNVs) impacts decision-making and concern. Findings suggest women, but less so partners, generally understand the nature and clinical implications of prenatal CMA results. Couples feel reassured, perhaps sometimes falsely so, when a CNV is inherited from a “normal” parent and experience considerable uncertainty when a CNV is de novo, frequently precipitating a search for additional information and guidance. Five factors influenced participants’ concern including: the pattern of inheritance, type of possible phenotypic involvement, perceived manageability of outcomes, availability and strength of evidence about outcomes associated with the CNV, and provider messages about continuing the pregnancy. A good understanding of results is vital as couples decide whether or not to continue with their pregnancy and seek additional information to assist in pregnancy decision-making.
Similar content being viewed by others
References
Alsulaiman, A., Hewison, J., Abu-Amero, K. K., Ahmed, S., Green, J. M., & Hirst, J. (2012). Attitudes to prenatal diagnosis and termination of pregnancy for 30 conditions among women in Saudi Arabia and the UK. Prenatal Diagnosis, 32, 1109–1113. doi:10.1002/pd.3967.
American College of Obstetricians and Gynecologists. (2013). Committee opinion no. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstetrics and Gynecology, 122, 1374–1377. doi:10.1097/01.AOG.0000438962.16108.d1.
Bernhardt, B. A., Soucier, D., Hanson, K., Savage, M. S., Jackson, L., & Wapner, R. J. (2013). Women’s experiences receiving abnormal prenatal chromosomal microarray testing results. Genetics in Medicine, 15, 139–45. doi:10.1038/gim.2012.113.
Bernhardt, B. A., Kellom, K., Barbarese, A., Faucett, W. A., & Wapner, R. J. (2014). An exploration of genetic counselors’ needs and experiences with prenatal chromosomal microarray testing. Journal of Genetic Counseling, 23, 938–947. doi:10.1007/s10897-014-9702-y.
Costain, G. (2015). Parental expression is overvalued in the interpretation of rare inherited variants. European Journal of Human Genetics, 23, 4–7. doi:10.1038/ejhg.2014.64.
Cox, D. M., & Butler, M. G. (2015). The 15q11.2 BP1-BP2 microdeletion syndrome: a review. International Journal of Molecular Sciences, 16, 4068–4082. doi:10.3390/ijms16024068.
Crolla, J. A., Wapner, R., & Van Lith, J. M. M. (2014). Controversies in prenatal diagnosis 3: should everyone undergoing invasive testing have a microarray? Prenatal Diagnosis, 34, 18–22. doi:10.1002/pd.4287.
Cypowyj, C., Eisinger, F., Huiart, L., Sobol, H., Morin, M., & Julian-Reynier, C. (2009). Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives. Psycho-Oncology, 18, 209–15. doi:10.1002/pon.1407.
Faas, B. H. (2015). Prenatal genetic care: debates and considerations of the past, present and future. Expert Opinion on Biological Therapy, 15, 1101–1105. doi:10.1517/14712598.2015.1045873.
Finucane, B., Challman, T. D., Martin, C. L., & Ledbetter, D. H. (2015). Shift happens: family background influences clinical variability in genetic neurodevelopmental disorders. Genetics in Medicine. doi:10.1038/gim.2015.92.
Haga, S. B., Mills, R., Pollak, K. I., Rehder, C., Buchanan, A. H., Lipkus, I. M., & Datto, M. (2014). Developing patient-friendly genetic and genomic test reports: formats to promote patient engagement and understanding. Genome Medicine, 6, 58. doi:10.1186/s13073-014-0058-6.
Hanoch, Y., Miron-Shatz, T., Rolison, J. J., & Ozanne, E. (2014). Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy. Psycho-Oncology, 23, 1142–1148. doi:10.1002/pon.3537.
Hillman, S. C., Willams, D., Carss, K. J., McMullan, D. J., Hurles, M. E., & Kilby, M. D. (2015). Prenatal exome sequencing for fetuses with structural abnormalities: the next step. Ultrasound in Obstetrics & Gynecology, 45, 4–9. doi:10.1002/uog.14653.
Kaphingst, K. A., Lachance, C. R., Gepp, A., Hoyt D’Anna, L., & Rios-Ellis, B. (2009). Educating underserved Latino communities about family health history using lay health advisors. Public Health Genomics, 14(4–5), 211–221. doi:10.1159%2F000272456.
Kearney, H. M., Thorland, E. C., Brown, K. K., Quintero-Rivera, F., & South, S. T. (2011). American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genetics in Medicine, 13, 680–685. doi:10.1097/GIM.0b013e3182217a3a.
Kiedrowski, L. A., Owens, K. M., Yashar, B. M., & Schuette, J. L. (2015). Parents’ perspectives on variants of uncertain significance from chromosome microarray analysis. Journal of Genetic Counseling. doi:10.1007/s10897-015-9847-3.
Kripalani, S., Bengtzen, R., Henderson, L. E., & Jacobson, T. A. (2008). Clinical research in low-literacy populations: using teach-back to assess comprehension of informed consent and privacy information. IRB, 30, 13–19. doi:10.1007/s10865-015-9642-5.
Lagan, B. M., Sinclair, M., & Kernohan, W. G. (2010). Internet use in pregnancy informs women’s decision making: a web-based survey. Birth, 37, 106–115. doi:10.1111/j.1523-536X.2010.00390.x.
Lowther, C., Costain, G., & Bassett, A. S. (2015). Reproductive genetic testing and human genetic variation in the era of genomic medicine. The American Journal of Bioethics, 15, 25–26. doi:10.1080/15265161.2015.1028661.
Martin, C. L., Kirkpatrick, B. E., & Ledbetter, D. H. (2015). Copy number variants, aneuploidies, and human disease. Clinics in Perinatology, 42, 227–242. doi:10.1016/j.clp.2015.03.001.
McCoyd, J. (2008). “I’m not a saint”: burden assessment as an unrecognized factor in prenatal decision making. Qualitative Health Research, 18, 1489–1500. doi:10.1177/1049732308325642.
Mikhaelian, M., Veach, P. M., MacFarlane, I., LeRoy, B. S., & Bower, M. (2013). Prenatal chromosomal microarray analysis: a survey of prenatal genetic counselors’ experiences and attitudes. Prenatal Diagnosis, 33, 371–377. doi:10.1002/pd.4071.
Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis. An expanded sourcebook (2nd ed., pp. 55–103). Thousand Oaks: Sage Publications.
Muller, C., & Cameron, L. D. (2015). It’s complicated: factors predicting decisional conflict in prenatal diagnostic testing. Health Expectations. doi:10.1111/hex.12363.
Nahar, R., Puri, R. D., Saxena, R., & Verma, I. C. (2013). Do parental perceptions and motivations towards genetic testing and prenatal diagnosis for deafness vary in different cultures? American Journal of Medical Genetics, 161A, 76–81. doi:10.1002/ajmg.a.35692.
Nielson-Bohlman, L., Panzer, A., & Kindig, D. (2004). Health literacy: A prescription to end confusion. Washington: National Academic Press.
Norton, M. E., Nakagawa, S., & Kuppermann, M. (2014). Women’s attitudes regarding prenatal testing for a range of congenital disorders of varying severity. Journal of Clinical Medicine, 3, 144–152. doi:10.3390/jcm3010144.
Pieters, J. J., Kooper, A. J., Eggink, A. J., Verhaak, C. M., Otten, B. J., Braat, D. D., & van Leeuwen, E. (2011). Parents’ perspectives on the unforeseen finding of a fetal sex chromosomal aneuploidy. Prenatal Diagnosis, 31, 286–292. doi:10.1002/pd.2707.
Pilnick, A., & Zayts, O. (2014). “It’s just a likelihood”: uncertainty as topic and resource in conveying “positive” results in an antenatal screening clinic. Symbolic Interaction, 37, 187–208. doi:10.1002/symb.99.
Reiff, M., Bernhardt, B. A., Mulchandani, S., Soucier, D., Cornell, D., Pyeritz, R. E., & Spinner, N. B. (2012). “What does it mean?”: uncertainties in understanding results of chromosomal microarray testing. Genetics in Medicine, 14, 250–258. doi:10.1038/gim.2011.52.
Reiff, M., Giarelli, E., Bernhardt, B. A., Easley, E., Spinner, N. B., Sankar, P. L., & Mulchandani, S. (2015). Parents’ perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 45, 3262–3275. doi:10.1007/s10803-015-2489-3.
Richards, E. G., Sangi-Haghpeykar, H., McGuire, A. L., Van den Veyver, I. B., & Fruhman, G. (2015). Pregnant patients’ risk perception of prenatal test results with uncertain fetal clinical significance: ultrasound versus advanced genetic testing. Prenatal Diagnosis. doi:10.1002/pd.4680.
Roche, M. I., & Skinner, D. (2009). How parents search, interpret, and evaluate genetic information obtained from the internet. Journal of Genetic Counseling, 18, 119–129. doi:10.1007/s10897-008-9198-4.
Sandelowski, M., & Barroso, J. (2005). The travesty of choosing after positive prenatal diagnosis. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 34, 307–318. doi:10.1177/0884217505276291.
Semaka, A., Balneaves, L. G., & Hayden, M. R. (2013). “Grasping the grey”: patient understanding and interpretation of an intermediate allele predictive test result for Huntington disease. Journal of Genetic Counseling, 22, 200–217. doi:10.1007/s10897-012-9533-7.
Taber, J. M., Klein, W. M. P., Ferrer, R. A., Han, P. K. J., Lewis, K. L., Biesecker, L. G., & Biesecker, B. B. (2015). Perceived ambiguity as a barrier to intentions to learn genome sequencing results. Journal of Behavioral Medicine, 38, 715–726. doi:10.1007/s10865-015-9642-5.
Turbitt, E., Halliday, J. L., Amor, D. J., & Metcalfe, S. A. (2015). Preferences for results from genomic microarrays: comparing parents and health care providers. Clinical Genetics, 87, 21–29. doi:10.1111/cge.12398.
Van der Steen, S. L., Diderich, K. E., Riedijk, S. R., Verhagen-Visser, J., Govaerts, L. C., Joosten, M., & Galjaard, R. J. (2015). Pregnant couples at increased risk for common aneuploidies choose maximal information from invasive genetic testing. Clinical Genetics, 88, 25–31. doi:10.1111/cge.12479.
Walser, S. A., Kellom, K. S., Palmer, S. C., & Bernhardt, B. A. (2015). Comparing genetic counselor’s and patient’s perceptions of needs in prenatal chromosomal microarray testing. Prenatal Diagnosis, 35, 870–878. doi:10.1002/pd.4624.
Wapner, R. J., Martin, C. L., Levy, B., Ballif, B. C., Eng, C. M., Zachary, J. M., & Jackson, L. (2012). Chromosomal microarray versus karyotyping for prenatal diagnosis. The New England Journal of Medicine, 367, 2175–2184. doi:10.1056/NEJMoa1203382.
Werner-Lin, A., Barg, F. K., Kellom, K. S., Stumm, K. J., Pilchman, L., Tomlinson, A. N., & Bernhardt, B. A. (2015). Couple’s narratives of communion and isolation following abnormal prenatal microarray testing results. Qualitative Health Research. doi:10.1177/1049732315603367.
Werner-Lin, A. McCoyd, J., & Bernhardt, B. A. Recommendations for psychosocial genetic counseling during prenatal cytogenetic microarray analysis: Addressing uncertainty with more than just information. (under review) .
White, M., Garbez, R., Carroll, M., Brinker, E., & Howie-Esquivel, J. (2013). Is “teach-back” associated with knowledge retention and hospital readmission in hospitalized heart failure patients? The Journal of Cardiovascular Nursing, 28, 137–146. doi:10.1097/JCN.0b013e31824987bd.
Willis, A. M., Smith, S. K., Meiser, B., Muller, C., Lewis, S., & Halliday, J. (2015). How do prospective parents prefer to receive information about prenatal screening and diagnostic testing? Prenatal Diagnosis, 35, 100–102. doi:10.1002/pd.4493.
Acknowledgments
This work was supported by funding from the National Institute of Child Health and Development, National Institutes of Health (UO1-HD-055651). There was no additional involvement from funding sources.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Sarah Walser, Allison Werner-Lin, Amita Russell, Ronald Wapner, and Barbara Bernhardt declare they have no conflict of interest.
Human Studies and Informed Consent
All procedures performed as part of the work for this publication were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all patients for being included in the study.
Animal Studies
No animal studies were carried out by the authors for this article.
Rights and permissions
About this article
Cite this article
Walser, S.A., Werner-Lin, A., Russell, A. et al. “Something Extra on Chromosome 5”: Parents’ Understanding of Positive Prenatal Chromosomal Microarray Analysis (CMA) Results. J Genet Counsel 25, 1116–1126 (2016). https://doi.org/10.1007/s10897-016-9943-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-016-9943-z